A pioneering study at UKZN has demonstrated that 20% of HIV patients in the trial remained off antiretroviral therapy while ...
Sunday Tribune on MSN9d
Some Won’t Survive: US cuts threaten Africa’s young HIV patientsUS funding cuts have led to severe rationing of HIV medication in Kenya, leaving countless young patients like Alice Okwirry ...
First things first: no one is arguing that low-and middle-income countries (LMICs) should continue to receive foreign aid in ...
Dr. Mabowa Makhomisane leads a vital HIV initiative in Limpopo, aiming for a unified African response to combat the epidemic.
The drug's manufacturer, Gilead Sciences, might be able to get some results to regulators by 2027, Mitchell Warren, chief ...
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
and amounted to 17 percent of South Africa's overall HIV response. "It's about much more than medicine," said Sibongile ...
South Africa has one of the highest rates of HIV ... who chairs the Treatment Action Campaign, a leading HIV advocacy organisation. "It's about a person finding a friendly healthcare worker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback